Chlamydia trachomatis infection is associated with pelvic inflammatory dise
ase (PID) and tubal factor infertility (TFI). We investigated the role of C
. trachomatis as a target antigen of endometrial and salpingeal tissue lymp
hocytes derived from PID and TFI patients. Antigen specificity of the tissu
e originated T lymphocyte lines (TLL) was tested against C, trachomatis ele
mentary bodies and chlamydial heat shock protein 60 (CHSP60). C. trachomati
s antigen stimulated proliferation in two out of eight endometrial TLL deri
ved from PID patients and three out of four TLL derived from TFI patients.
All (n = 4) TLL derived from the salpingeal specimens responded to CHSP60 c
ompared with only one out of 12 TLL derived from the endometrial specimens.
In-vivo expression of interferon-gamma (IFN-gamma) mRNA revealed that it w
as present in nine of 13 specimens obtained from PID patients. The dominant
activity of type-1 T lymphocytes was confirmed by the in-vitro production
of IFN-gamma (median 1007 pg/ml) from all (n = 5) C, trachomatis specific T
LL while IL-5 secretion was lower (median 779 pg/ml). In conclusion, C, tra
chomatis reactive TLL were established from in-vivo activated lymphocytes f
rom the upper genital tract tissue of PID and TFI patients. The reactivity
of the salpingeal TLL to CHSP60 provided further evidence that immunoreacti
vity to CHSP60 is a predominant response in patients with tubal damage.